177 related articles for article (PubMed ID: 34632302)
1. Upregulation of IL-1 Receptor Antagonist by Aspirin in Glial Cells via Peroxisome Proliferator-Activated Receptor-Alpha.
Chakrabarti S; Prorok T; Roy A; Patel D; Dasarathi S; Pahan K
J Alzheimers Dis Rep; 2021; 5(1):647-661. PubMed ID: 34632302
[TBL] [Abstract][Full Text] [Related]
2. Aspirin up-regulates suppressor of cytokine signaling 3 in glial cells via PPARα.
Chakrabarti S; Roy A; Prorok T; Patel D; Dasarathi S; Pahan K
J Neurochem; 2019 Oct; 151(1):50-63. PubMed ID: 31273781
[TBL] [Abstract][Full Text] [Related]
3. Activation of the peroxisome proliferator-activated receptor alpha pathway potentiates interleukin-1 receptor antagonist production in cytokine-treated chondrocytes.
François M; Richette P; Tsagris L; Fitting C; Lemay C; Benallaoua M; Tahiri K; Corvol MT
Arthritis Rheum; 2006 Apr; 54(4):1233-45. PubMed ID: 16572457
[TBL] [Abstract][Full Text] [Related]
4. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
[TBL] [Abstract][Full Text] [Related]
5. Aspirin Induces Lysosomal Biogenesis and Attenuates Amyloid Plaque Pathology in a Mouse Model of Alzheimer's Disease via PPARα.
Chandra S; Jana M; Pahan K
J Neurosci; 2018 Jul; 38(30):6682-6699. PubMed ID: 29967008
[TBL] [Abstract][Full Text] [Related]
6. The Interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver.
Stienstra R; Mandard S; Tan NS; Wahli W; Trautwein C; Richardson TA; Lichtenauer-Kaligis E; Kersten S; Müller M
J Hepatol; 2007 May; 46(5):869-77. PubMed ID: 17321000
[TBL] [Abstract][Full Text] [Related]
7. Treadmill workout activates PPARα in the hippocampus to upregulate ADAM10, decrease plaques and improve cognitive functions in 5XFAD mouse model of Alzheimer's disease.
Rangasamy SB; Jana M; Dasarathi S; Kundu M; Pahan K
Brain Behav Immun; 2023 Mar; 109():204-218. PubMed ID: 36682514
[TBL] [Abstract][Full Text] [Related]
8. Identification of Cinnamein, a Component of Balsam of Tolu/Peru, as a New Ligand of PPARα for Plaque Reduction and Memory Protection in a Mouse Model of Alzheimer's Disease.
McKay M; Gorai S; Paidi RK; Mondal S; Pahan K
J Alzheimers Dis Rep; 2024; 8(1):903-922. PubMed ID: 38910936
[TBL] [Abstract][Full Text] [Related]
9. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
Corbett GT; Gonzalez FJ; Pahan K
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of Suppressor of Cytokine Signaling 3 in Microglia by Cinnamic Acid.
Chakrabarti S; Jana M; Roy A; Pahan K
Curr Alzheimer Res; 2018; 15(10):894-904. PubMed ID: 29732971
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
[TBL] [Abstract][Full Text] [Related]
12. Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity.
Sumanasekera WK; Tien ES; Davis JW; Turpey R; Perdew GH; Vanden Heuvel JP
Biochemistry; 2003 Sep; 42(36):10726-35. PubMed ID: 12962497
[TBL] [Abstract][Full Text] [Related]
13. [Protective effect of glycogen synthase kinase 3β inhibition via peroxisome proliferator-activated receptor alpha activation in mice with acute liver failure].
Shi HB; Shi HL; Zhang XY; Chen DX; Duan ZP; Ren F
Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):211-216. PubMed ID: 28482409
[No Abstract] [Full Text] [Related]
14. Gemfibrozil Protects Dopaminergic Neurons in a Mouse Model of Parkinson's Disease via PPARα-Dependent Astrocytic GDNF Pathway.
Gottschalk CG; Jana M; Roy A; Patel DR; Pahan K
J Neurosci; 2021 Mar; 41(10):2287-2300. PubMed ID: 33514677
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective actions of endogenous interleukin-1 receptor antagonist (IL-1ra) are mediated by glia.
Pinteaux E; Rothwell NJ; Boutin H
Glia; 2006 Apr; 53(5):551-6. PubMed ID: 16374779
[TBL] [Abstract][Full Text] [Related]
16. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
17. Intravenous transplantation of olfactory ensheathing cells reduces neuroinflammation after spinal cord injury
Zhang L; Zhuang X; Kotitalo P; Keller T; Krzyczmonik A; Haaparanta-Solin M; Solin O; Forsback S; Grönroos TJ; Han C; López-Picón FR; Xia H
Theranostics; 2021; 11(3):1147-1161. PubMed ID: 33391526
[No Abstract] [Full Text] [Related]
18. [Cellular and molecular mechanisms of anti-inflammatory effect of peroxisome proliferator-activated receptor α].
Jiao MJ; Zhou L; Ren F; Wang YD; Shen C; Duan ZP; Zhao CY
Zhonghua Gan Zang Bing Za Zhi; 2016 Dec; 24(12):916-920. PubMed ID: 28073413
[No Abstract] [Full Text] [Related]
19. Activation of PPARα Exhibits Therapeutic Efficacy in a Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis.
Jana M; Dutta D; Poddar J; Pahan K
J Neurosci; 2023 Mar; 43(10):1814-1829. PubMed ID: 36697260
[TBL] [Abstract][Full Text] [Related]
20. Regulation of peroxisome proliferator-activated receptors (PPAR) α and -γ of rat brain astrocytes in the course of activation by toll-like receptor agonists.
Chistyakov DV; Aleshin SE; Astakhova AA; Sergeeva MG; Reiser G
J Neurochem; 2015 Jul; 134(1):113-24. PubMed ID: 25818681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
